Home › Funds › Lynx1 Capital Management LP › BOLT

Lynx1 Capital Management LP position in BOLT

BOLT BIOTHERAPEUTICS INC · Health Care

Lynx1 Capital Management LP reported holding 30,800 shares of BOLT (BOLT BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$119K, representing 0.01% of its reported portfolio and ranking #24 among its reported holdings. Lynx1 Capital Management LP has disclosed BOLT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)30.80K sh
Reported value held$118.58K
Portfolio Weight0.01%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's BOLT position evolved

Lynx1 Capital Management LP first disclosed a stake in BOLT in Q1 2026 at 30,800 shares (US$124K). Across 2 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 30,800 shares valued at US$119K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 30.80K $124.43K New
Q2 2026 30.80K $118.58K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BOLT and 13F data

BOLT (BOLT BIOTHERAPEUTICS INC) is a Health Care company. 15 other funds we track also report a position in BOLT — the largest reported positions include Vivo Capital, LLC (US$279K), Board of Trustees of The Leland Stanford Junior University (US$139K), PFIZER INC (US$134K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BOLT

All BOLT fund holders →

FAQ

How long has Lynx1 Capital Management LP held BOLT?

Lynx1 Capital Management LP has disclosed BOLT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Lynx1 Capital Management LP's current position in BOLT?

As of Q2 2026, Lynx1 Capital Management LP holds 30.80K shares of BOLT (BOLT BIOTHERAPEUTICS INC), valued at $118.58K, representing 0.01% of its reported portfolio and ranking #24.

Has Lynx1 Capital Management LP been buying or selling BOLT?

In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP held unchanged its position in BOLT.

Which other funds hold BOLT?

Other major institutional holders of BOLT include Vivo Capital, LLC, Board of Trustees of The Leland Stanford Junior University, PFIZER INC, among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.